TrialInternational journal of rheumatic diseases2026

Efficacy and Safety of Ultra-Low Starting Dose Febuxostat Titration in Male Patients With Primary Gout.

Sun Huizhen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.